<DOC>
	<DOCNO>NCT01948583</DOCNO>
	<brief_summary>Aim study evaluate humectant activity local tolerability new formulation Gynomunal® vaginalgel menopausal woman ( menopause since least 2 year ) refer vaginal dryness</brief_summary>
	<brief_title>Humectant Activity New Formulation Gynomunal® Vaginalgel</brief_title>
	<detailed_description>Randomized , control , crossover clinical study ; subject use formulation interval 1 week ( wash period ) , reverse sequence accord treatment arm assign subject basal visit . Both tested product apply vagina , use dedicate applicator , day , preferably bedtime . To investigate activity product study , 4 visit perform : baseline visit ( T0 ) , visit end first week-treatment ( T1 ) , visit end wash period ( T2 ) final visit end second week-treatment ( T3 ) . Volunteers ask follow normal life sexual habit , except sexual intercourse 48 hour prior examination .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Caucasian healthy female subject , complain vaginal dryness , woman menopause since least 2 year ; start period menopause define date last menstruation metrorragia link hormonal unbalance take place , woman agree start replacement therapy whole duration study , woman present active cutaneous pathology external internal genitalia , woman receive drug cosmetic treatment genitalia 2 month precede trial , woman apply vaginal product within least 1 month inclusion study , woman accept use product authorise protocol , woman accept undertake treatment internal external genitalia trial , woman use , phytoestrogenes base product treat area less 4 week inclusion time , woman accept sign Informed consent form , woman able read material dedicate volunteer , abide rule protocol ready accept constraint Volunteers fulfil inclusion criterion , severe symptom vaginal dryness , associate mucosal sign history intolerance vaginal product , concomitant participation another trial , refusal sign Informed Consent form , know allergy one several ingredient product trial , change normal habit last 3 month , participation similar study previous 3 month , whose insufficient adhesion study protocol foreseeable woman start replacement therapy trial woman experience study occurrence foreseeable risk use daily product trial .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>vaginal dryness</keyword>
	<keyword>hyaluronic acid</keyword>
	<keyword>menopause</keyword>
</DOC>